Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia
Conclusions/interpretationThis study shows, for the first time, the occurrence of sensory neuropathy in the bone marrow of type 1 diabetic mice, which translates into an altered modulation of substance P and depressed release of substance P-responsive stem cells following ischaemia.NGF therapy improves bone marrow sensory innervation, with benefits for healing on the occurrence of peripheral ischaemia. Nociceptors may represent a new target for the treatment of ischaemic complications in diabetes.
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Brain | Depression | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Gene Therapy | Genetics | Neurology | Stem Cell Therapy | Stem Cells | Students | Study | Universities & Medical Training